EXHIBIT 31.1
                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                   PURSUANT TO RULES 13a-14 AND 15d-14 OF THE
                         SECURITIES EXCHANGE ACT OF 1934

I, Wolfgang  Barnikol,  Chief Executive  Officer and Chief Financial  Officer of
Sangui BioTech International, Inc. (the "Company"), certify that:

         I have reviewed this quarterly  report on Form 10-QSB of Sangui BioTech
International, Inc.

         Based on my  knowledge,  this  quarterly  report  does not  contain any
untrue  statement of a material fact or omit to state a material fact  necessary
to make the  statements  made,  in light of the  circumstances  under which such
statements  were made, not misleading with respect to the period covered by this
quarterly report.

         Based on my knowledge,  the financial  statements,  and other financial
information included in the report,  fairly present in all material respects the
financial condition,  results of operations and cash flows of the Company as of,
and for, the periods, presented in the report.

         The  Company's  other  certifying  officer  and I are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the Company and have:

            (a) designed such disclosure controls and procedures, or caused such
            disclosure   controls  and   procedures  to  be  designed  under  my
            supervision,  to ensure that  material  information  relating to the
            Company, including its consolidated  subsidiaries,  is made known to
            me by others within those entities,  particularly  during the period
            in which the periodic report is being prepared;

            (b) evaluated the effectiveness of the Company's disclosure controls
            and  procedures and presented in this report our  conclusions  about
            the effectiveness of the disclosure  controls and procedures,  as of
            the end of the period covered by this quarterly report based on such
            evaluation; and

            (c) disclosed in this  quarterly  report any change in the Company's
            internal  control over financial  reporting that occurred during the
            Company's most recent fiscal  quarter that has materially  affected,
            or is reasonably likely to materially affect, the Company's internal
            control over financial reporting; and

         The Company's other certifying  officer and I have disclosed,  based on
our most recent evaluation of internal control over financial reporting,  to the
Company's  auditors and to the audit  committee  of the board of  directors  (or
persons fulfilling the equivalent function):

            (i) all  significant  deficiencies  in the  design or  operation  of
            internal  control  over  financial  reporting  which are  reasonably
            likely to adversely affect the Company's ability to record, process,
            summarize and report financial information; and

            (ii) any fraud, whether or not material, that involves management or
            other  employees  who  have a  significant  role  in  the  Company's
            internal control over financial reporting.


Date: February 16, 2004                  By: /s/ Wolfgang. Barnikol
                                             --------------------------
                                             Wolfgang Barnikol, Chief Executive
                                             Officer and Chief Financial Officer


                                                                            -13-